Although various studies have deepened our understanding of HCC carcinogenesis, HCC surveillance mainly relies on abdominal ultrasonography and blood alpha-fetoprotein (AFP) measurements in high-risk groups with hepatitis B, hepatitis C, and liver cirrhosis (LC) [3–5]. The gene discussed is AFP; the disease is hepatocellular carcinoma.